Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
51.71
-4.08 (-7.31%)
At close: May 21, 2026
SHE:301033 Market Cap
SHE:301033 has a market cap or net worth of 3.45 billion as of May 21, 2026. Its market cap has increased by 4.86% in one year.
Market Cap
3.45B
Enterprise Value
3.16B
Revenue
373.49M
Ranking
n/a
PE Ratio
31.52
Stock Price
51.71
Market Cap Chart
Since July 26, 2021, SHE:301033's market cap has decreased from 4.69B to 3.45B, a decrease of -26.50%. That is a compound annual growth rate of -6.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 3.72B | -17.35% |
| Dec 31, 2025 | 4.50B | 61.81% |
| Dec 31, 2024 | 2.78B | -3.27% |
| Dec 29, 2023 | 2.88B | 18.06% |
| Dec 30, 2022 | 2.44B | -39.66% |
| Dec 31, 2021 | 4.04B | -13.95% |
| Jul 26, 2021 | 4.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GKHT Medical Technology | 4.64B |
| Zhejiang Orient Gene Biotech | 4.44B |
| Nanjing Medlander Medical Technology | 4.27B |
| Chison Medical Technologies | 3.89B |
| Wuhan Easy Diagnosis Biomedicine | 3.66B |
| Shanghai ZJ Bio-Tech | 3.60B |
| Beijing Leadman Biochemistry | 3.54B |
| Kontour (Xi'an) Medical Technology | 3.53B |